JNJ Johnson & Johnson
P/E
40.61
Forward P/E
21.01
Price/Sales
6.49
Beta
0.206
Div Yield
0.0205%
Market Cap
--
Company Analysis
Latest News
Johnson & Johnson to Reveal Varipulse Data Following European Launch
Johnson & Johnson will present 12-month interim results from its VARIPURE study at the 2026 PFA Summit. The company scheduled the data presentation for April...
Johnson & Johnson launches VARIPULSE in Europe, targeting common heart rhythm disorders
Johnson & Johnson launched the VARIPULSE Pro Platform in Europe following CE Mark approval. The device utilizes pulsed field ablation (PFA) to treat atrial...